Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001) (Q35703129)
Jump to navigation
Jump to search
scientific article published on 18 June 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001) |
scientific article published on 18 June 2014 |
Statements
Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001) (English)
T Dragovich
D Laheru
F Dayyani
V Bolejack
L Smith
J Seng
H Burris
P Rosen
P Ritch
A F Baker
N Raghunand
J Crowley
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference